OOIR: Observatory of International Research

Papers

(The TQCC of Allergy and Asthma Proceedings is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Impact of steroids on the immune profiles of children with asthma living in the inner-city	33
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination	28
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis	26
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children	24
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis	23
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being	21
Operationalizing shared decision making in clinical practice	21
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks	20
Breathing through the night: A meta-analysis of childhood asthma and obstructive sleep apnea in sleep-disordered contexts	20
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study	20
For the Patient	18
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 2022	18
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes	17
For the Patient	17
TEV/FEV₃ as a coherent metric of small airway dysfunction in childhood asthma	15
Evaluation and management of chronic cough in adults	15
Optimizing diagnostic approaches for allergic bronchopulmonary aspergillosis: Comparative analysis of IgG/IgE ELISA and serum precipitins assays	15
Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy	15
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity	15
Recurrent full-body rash following chemotherapy initiation in a multiple myeloma patient	14
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis	13
The burden of systemic corticosteroids in patients with chronic rhinosinusitis with nasal polyps	13
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course	13
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy	13
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome	12

Diagnostic utility of basophil CD203c expression in β-lactam allergy	12
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics	12
For the Patient	12
Effects of mechanical washing and drying on the removal of pet allergens	12
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department	12
Utility of basophil activation tests in the diagnosis of cross-intolerance to nonsteroidal anti-inflammatory drug reactions	12
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs	12
Artificial intelligence and allergy: Shaping the future of diagnosis and therapy	11
Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment	11
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii	11
Navigating the management complexity in long-term asymptomatic immunodeficiency	11
A tribute to allergy and immunology fellowship training program directors and to the fellows they train	11
Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?	11
From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention	10
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities	10
Exhaled breath condensate thymic stromal lymphopoietin, OX40 ligand, eotaxin, and interleukin-23 in children with atopic dermatitis and persistent wheeze	10
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab	10
For the patient	10
Metal implant allergy: A retrospective cohort analysis at a university allergy practice	9
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study	9
Evaluation of atopic diseases in patients with allergic contact dermatitis	9
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible	9
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii	9
Primary Immunodeficiency: Specific antibody deficiency with normal IgG	9
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination	9
The long COVID syndrome: A conundrum for the allergist/immunologist	9
Hematopoietic stem cell transplantation for primary immunodeficiency	9
Benralizumab in the management of rare primary eosinophilic lung diseases	8
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization	8
Rethinking the management of hereditary angioedema	8
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center	8
Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization	8
Follow-up after discontinuation of omalizumab in patients with moderate-to-severe asthma: A systematic review	8
Overview of secondary immunodeficiency	8
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab	8
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH	8
Curcumin does not significantly affect immediate skin tests	8
Cost-effectiveness of school integrated pest management and air filtration in students with asthma	8
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives	8
The impact of dietary patterns on the risk of asthma in children	8
For the Patient	8
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis	8
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis	7
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis	7
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	7
Multicenter questionnaire study investigating characteristics of adults with unexplained chronic cough versus explained chronic cough	7
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic	7
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)	7
Delayed pressure urticaria successfully treated with omalizumab: A tertiary-level health-care center experience	7
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study	7

Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy	7
Quality of life and burden of disease in patients with hereditary angioedema and their caregivers	7
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis	7
Winged hymenoptera: Discordance between In vitro and In vivo sensitization	7
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience	7
Patterns of epinephrine prescribing at discharge and length of stay for adult anaphylaxis in U.S. emergency departments	7
Vaccinating patients on biologics for atopic disease: Clinical considerations and evidence-based recommendations	7
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study	7
Immunodeficiency: Burden of Illness	7
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort	7
A masquerade of recurrent anaphylaxis	6
For the patient	6
Genetically-determined defects of T cell development	6
Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma	6
Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria	6
Peanut allergy in an adult following cardiac transplant from a non-atopic donor	6
Abstracts presented at the Eastern Allergy Conference, June 2‐5, 2022, Palm Beach, Florida	6
Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal	6
Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis	6
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis	6
Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease	6
Impact of perinatal risk factors on pediatric asthma: A systematic review and meta-analysis	6
Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis	6